Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cannara Biotech Inc
(OP:
LOVFF
)
0.5372
UNCHANGED
Streaming Delayed Price
Updated: 2:57 PM EDT, Aug 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cannara Biotech Inc
< Previous
1
2
Next >
Cannara Biotech Reports 6% YoY Drop In Q3 Gross Profit, 22% Revenue Increase As It Enhances Sales Force And Infrastructure
July 23, 2024
Vertically integrated cannabis company Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0) announced on Tuesday its fiscal third quarter 2024 financial and operating results for the three and...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannara Biotech Reports Q3 2024 Financial Results
July 23, 2024
From
Cannara Biotech (Québec) Inc.
Via
GlobeNewswire
Cannabis Slowdown In Canada: Analyst Spotlights What Still Sells And Where The Money Is Going
June 03, 2024
In a recent report, Pablo Zuanic of Zuanic & Associates analyzed trends in Canada's recreational cannabis market through May 2024. The report highlights a deceleration in market growth and notable...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannara Biotech Reports 51% YoY Revenue Increase In Q2, Wider Net Loss
May 01, 2024
Cannara Biotech Inc. announced on Monday its fiscal second quarter 2024 financial and operating results for the three and six-month periods ended Feb. 29, 2024. The company reported a 68%...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
This Cannabis Producer Reports It Is Able to Deliver Some Of The Highest Quality Product To Market At Some Of The Most Competitive Prices
December 20, 2023
--News Direct--
Via
News Direct
Topics
Cannabis
Exposures
Cannabis
The 7 Most Undervalued Cannabis Stocks to Buy in December
December 14, 2023
These seven cannabis stocks are either undervalued based on traditional metrics, or are undervalued relative to future potential.
Via
InvestorPlace
Topics
Cannabis
Exposures
Cannabis
This Cannabis Producer Reports It Is Able to Deliver Some Of The Highest Quality Product To Market At Some Of The Most Competitive Prices
December 07, 2023
Nicholas Sosiak, CFO of Cannara Biotech (TSXV: LOVE.V) (OTCQB: LOVFF) (FRA: 8CB) was recently interviewed by Benzinga.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023
August 21, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
7 Smoking-Hot 420 Stocks to Buy in 2023
August 17, 2023
A blaze of renewed bullishness may be just around the corner for these seven cannabis plays, making them top 420 stocks to buy.
Via
InvestorPlace
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Movers For August 10, 2023
August 10, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannara Biotech Q3 FY23 Net Revenue Grows 57% YoY, What About Adjusted EBITDA?
July 27, 2023
Cannara Biotech Inc.
Via
Benzinga
Cannabis Stock Gainers And Losers From July 25, 2023
July 25, 2023
Via
Benzinga
Cannabis Stock Gainers And Losers From August 4, 2023
August 04, 2023
Via
Benzinga
Cannara Biotech Secures An Additional $10M In Non-Dilutive Capital With Its Lead Credit Provider, BMO Commercial Banking
May 04, 2023
Cannara Biotech Inc.
Via
Benzinga
Cannara Biotech Q2 FY23 Revenue Grows 76% YoY To $9.6M, Here Are The Details
April 24, 2023
Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA:8CB) released its fiscal second quarter 2023 financial results, revealing net revenue of CA$13 million ($9.6 million), a 76% increase, compared to...
Via
Benzinga
Marijuana Stock Movers For August 1, 2023
August 01, 2023
Via
Benzinga
Olymbec Investments Increases Its Ownership In Cannara Biotech
February 10, 2023
Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA:8CB) held its annual shareholder meeting on January 25, 2023.
Via
Benzinga
Cannara Biotech Q1 Revenue Grows 57% YoY To $7.7M, What About Adjusted EBITDA?
January 23, 2023
Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA: 8CB) released its fiscal first quarter 2023 financial results for the three-month period ended November 30, 2022, revealing revenue of CA$10.3...
Via
Benzinga
Cannabis Stock Movers For July 27, 2023
July 27, 2023
Via
Benzinga
Cannara Biotech Q4 Revenue Grows 84% YoY To $8.9M
November 28, 2022
Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA:8CB) released its fiscal fourth quarter and fiscal year 2022 financial results for the three-month and full year periods ended August 31, 2022,...
Via
Benzinga
Cannara Biotech Enters Into The British Columbia Cannabis Market And Launches New Products
September 20, 2022
Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA:8CB), a Quebec-based, vertically integrated producer of cannabis and derivative product offerings, entered into the British Columbia (BC) market.
Via
Benzinga
Cannara Biotech Signs An Exclusive Brand Partnership With Exotic Genetix In Canada
August 03, 2022
Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA: 8CB) entered into an exclusive brand partnership with Exotic Genetix Ltd.
Via
Benzinga
Cannara Biotech Revenue Grows 41% YoY, Here Are The Details
July 27, 2022
Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA:8CB) fiscal Q3 2022 revenue was $10.1 million, a 36% increase from the previous quarter and a 41% increase compared to Q3 2021.
Via
Benzinga
Cannara Biotech Closes $50 Million Credit Facility Led By BMO Commercial Banking
June 02, 2022
Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA:8CB) has closed on a $50M credit facility led by BMO Commercial Banking.
Via
Benzinga
Cannara Biotech Revenues Grew 229% To $7.4M In Q2 2022 YoY
April 27, 2022
Cannara Biotech Inc. (OTCQB: LOVFF) (TSXV:LOVE) (FRA: 8CB) released its fiscal second quarter 2022 financial and operating results for the three and six-month periods ended February 28, 2022.
Via
Benzinga
The Week In Cannabis: Isiah Thomas, Tilray, The DEA, Ohio, Mexico And More
December 10, 2021
Below is a recap of the main news related to the cannabis industry and markets for the week of December 6, 2021.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannara Biotech Shares Surge On 983% QoQ Revenue Growth, Positive Adjusted EBITDA
December 09, 2021
Vertically integrated cannabis company Cannara Biotech Inc. (TSXV:
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Tilray Best Performer Among Canadian Cannabis LPs, Stocks Plunge Nearly 10% In July
August 02, 2021
Canadian cannabis stocks took a beating In July, with the Canadian Cannabis LP Index posting a 9.8% loss while continuing the decl...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannara Biotech Cannabis Co. Slightly Beats Estimates, Posts $7.2M In Q3 2021 Revenue
July 29, 2021
Vertically integrated cannabis company Cannara Biotech Inc. (TSXV:
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
The Week In Cannabis: Justice Clarence Thomas, Mexico's Decriminalization, Apple's Policy Changes, Tilray And More
July 02, 2021
Below is a recap of the main news related to the cannabis industry and markets for the week of June 28, 2021. Justice Thomas&nbs...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.